In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

Oncology, and Biosecurity Amid Strategic Program Developments ATLANTA, GA - April 16, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.

The U.S. government continues to end contacts related to the $5 billion Project NextGen initiative, this time terminated ...

Federal cuts to funding could “decimate” medical research in the US, delaying cures and costing countless lives.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

CSIR's IICT, CCMB and NGRI have collaborated to organise a two-day 'CSIR Start-Up Conclave' on April 22 and 23 at Zahir ...

Key information     WHO approved an agreement regarding the fight against ...

Decoy’s development of novel peptide-conjugate therapeutics arising from its proprietary IMP3ACT™ platform to benefit from Dr ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...